SCHEMBL30585230

SCHEMBL30585230

CC1(C)CCC[C@@]2(C)[C@H]1CCC(=O)/[13C]2=C\O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.48
▸ PTPN2 P17706 2/20 0.40
▸ PTPN1 P18031 2/20 0.40
▸ USP2 O75604 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PIK3CA P42336 5/20 0.39
▸ PIK3CG P48736 5/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ CETP P11597 2/20 0.37
▸ TSHR P16473 1/20 0.36
▸ PNLIP P16233 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6422267 1.00 CYP19A1 (0.48) CYP19A1PTPN2PTPN1USP2TP53
SCHEMBL25435184 1.00 CYP19A1 (0.48) CYP19A1PTPN2PTPN1USP2TP53
SCHEMBL25436089 1.00 CYP19A1 (0.48) CYP19A1PTPN2PTPN1USP2TP53
SCHEMBL25432736 1.00 CYP19A1 (0.48) CYP19A1PTPN2PTPN1USP2TP53
SCHEMBL21917264 0.74 CYP19A1 (0.49) CYP19A1USP2TP53CYP3A4HSP90AA1
SCHEMBL14880005 0.74 CYP19A1 (0.49) CYP19A1USP2TP53CYP3A4HSP90AA1
SCHEMBL3146912 0.69 CYP19A1 (0.44) CYP19A1USP2TP53CYP3A4HSP90AA1
SCHEMBL266913 0.69 CYP19A1 (0.44) CYP19A1USP2TP53CYP3A4HSP90AA1
SCHEMBL16010818 0.67 USP2 (0.43) CYP19A1PTPN2PTPN1USP2TP53
SCHEMBL14879851 0.67 USP2 (0.43) CYP19A1PTPN2PTPN1USP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171391-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES FIRMENICH SA (CH) 2025-05-29 — — US disclosed
EP-4479369-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES Firmenich SA (CH) 2024-12-25 — — EP disclosed
WO-2023156429-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES FIRMENICH SA (CH) 2023-08-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171391-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES POR, NDUFV1, NDUFV2 CYP19A1 23/4885PTPN2 4240/4885PTPN1 4332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback